PatternsRadar
Sign in

MEDICOMedico Remedies Limited

NSEASM Stage IBand 10%
18.54INR-0.27 (-1.44%)Close · 20 Nov 2026
9 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹154 CrMarket cap
11.3P/E (TTM)
61.3%Delivery

Filings & corporate actions

19 results filed
CSV
Next results · Q3 FY27
Expected 5 Feb 2027 – 12 Feb 2027
Estimate: filed 36–43 days after quarter end, last 4 times
2026
  • 9 NovresultsResults · Q2 FY27 · standalone+0.2%NSE
  • 16 OctshareholdingShareholding · 30 Sept 2026+0.5%NSE
  • 13 AugresultsResults · Q1 FY27 · standalone-4.8%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+1.0%NSE
  • 21 MayresultsResults · Q4 FY26 · standalone+1.5%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+4.2%NSE
  • 13 AprresultsResults · Q3 FY26 · standalone+1.5%NSE
  • 12 FebresultsResults · Q3 FY26 · standalone-1.0%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025+2.3%NSE

Reaction to results · all yearsrose on day 0 in 7 of 18 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY279 Nov 2026+0.2%-3.4%—1.1×
Q1 FY2713 Aug 2026-4.8%-10.9%-22.6%1.2×
Q4 FY2621 May 2026+1.5%+1.0%-10.1%1.9×
Q3 FY2612 Feb 2026-1.0%-3.3%-16.5%0.1×
Q2 FY2614 Nov 2025-0.2%-7.8%-5.1%0.2×
Q1 FY268 Aug 2025-0.8%+6.5%-0.1%0.7×
Q4 FY258 May 2025-6.5%+1.8%-9.0%0.3×
Q3 FY255 Feb 2025+3.0%-8.7%-19.5%1.7×
Q2 FY2512 Nov 2024-0.1%-17.1%-10.8%3.5×
Q1 FY2512 Aug 2024-2.2%-0.3%+18.3%0.5×
Q4 FY249 May 2024+2.8%-5.4%-8.5%0.9×
Q3 FY2412 Feb 2024+0.4%+5.7%+2.7%0.9×
Q2 FY249 Nov 2023+0.7%+0.4%+11.1%0.8×
Q1 FY2410 Aug 2023-0.3%+3.4%-5.7%2.4×
Q4 FY2312 May 2023-1.5%+0.4%+0.5%0.7×
Q3 FY2310 Feb 2023-0.8%+4.3%+21.0%0.4×
Q2 FY2313 Nov 2022+4.5%+32.4%+50.8%1.1×
Q1 FY2312 Aug 2022-4.7%-4.2%+8.9%3.2×
Average-0.5%-0.3%+0.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+40.5%
Profit YoY-7.4%
Interest cost YoY+66.8%
Revenue QoQ+6.6%
Profit QoQ-5.5%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+35.4%+22.5%————
Profit+33.2%+20.6%————

Key data

Open19.15
Day range18.34 – 19.30
52-week range17.81 – 56.88
From 52w high-67.4%
RSI (14)34.0
ATR (14)1.11
Volume2.39L
Avg volume (20D)2.21L
Rel volume1.08×
Volatility (1Y)52.8%
Turnover₹44.8L
Traded value (NSE)₹44.8L
VWAP18.77
SMA 50 / 20023.54 / 37.88
Price band10%

Delivery percentage

Latest · 20 Nov 202661.3%
20-day avg70.6%
1-year avg58.9%
Percentile (own history)55th
Range8.3–100.0%
Sessions1,113

Over the last 20 sessions MEDICO settled 70.6% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 58.9%, so recent sessions are running 11.7 points higher than usual. The latest session ranks higher than 55% of the 1,113 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders17.7K · +11.7% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy108 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.44%+0.54%-9.56%-55.93%-60.65%-65.11%

Valuation

Market cap₹154 Cr
Market cap (NSE)₹154 Cr
Free-float cap₹59 Cr
P/E (TTM)11.3
P/E (NSE)11.5
EPS (TTM)1.64
P/B1.9
Net margin (TTM)5.3%
Other income / PBT32.1%
ROE18.5%
Debt / equity0.40
Shares outstanding8.30Cr
Listed26 May 2022

Ownership

Promoter61.38%
Promoter Δ QoQ0.00 pp
Public38.62%
FII0.60%
DII0.00%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)58.756.869.474.0
YoY chg+48.6%+37.5%+81.4%+40.5%
Net profit (₹ Cr)2.95.92.52.4
YoY chg+9.7%+34.9%+38.5%-7.4%
Net margin4.9%10.3%3.6%3.2%
EPS0.350.710.300.29

Shareholding over time

By quarter

30 Sept 2026 · promoter 61.38% · public 38.62%
30 Jun 2022: promoter 73.34%12 Jul 2022: promoter 73.34%30 Sept 2022: promoter 73.34%31 Dec 2022: promoter 73.34%17 Mar 2023: promoter 73.34%18 Mar 2023: promoter 73.34%31 Mar 2023: promoter 73.34%30 Jun 2023: promoter 73.34%30 Sept 2023: promoter 73.34%31 Dec 2023: promoter 73.34%31 Mar 2024: promoter 73.34%30 Jun 2024: promoter 73.34%30 Sept 2024: promoter 73.34%31 Dec 2024: promoter 66.83%31 Mar 2025: promoter 63.79%30 Jun 2025: promoter 62.59%30 Sept 2025: promoter 61.38%31 Dec 2025: promoter 61.38%31 Mar 2026: promoter 61.38%30 Jun 2026: promoter 61.38%30 Sept 2026: promoter 61.38%
2022-062026-09
  • Promoter
  • Public and others
Promoter
61.38%
Public
38.62%
Promoter change
0.00 pp
Filed
16 Oct 2026
FII
0.60%
DII
0.00%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.60%

+0.52 pp QoQ

Retail ≤ ₹2L
18.80%

+3.64 pp QoQ

HNI > ₹2L
5.97%

-2.55 pp QoQ

NRI
0.53%

-0.05 pp QoQ

Bodies corporate
4.06%

-0.66 pp QoQ

Shareholders
17,716

+11.7% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
HARESH KAPURLAL MEHTAPromoter · Individual20.22%
MEHTA RISHIT HARESHBHAIPromoter · Individual12.65%
HARSHIT HARESH MEHTAPromoter · Individual10.39%
RITA H MEHTAPromoter · Individual8.05%
SHWETA HARSHIT MEHTAPromoter · Individual5.88%
PRIYAL RISHIT MEHTAPromoter · Individual4.19%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
13
8 open-market of the newest 13
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
26 Dec 2024Shweta Harshit MehtaPromoterSell2.00L₹97.0L48.5063.60L → 61.60L7.42%-0.24 pp7(2)told 25 Dec 2024
26 Dec 2024Harshit H Mehta HUFPromoterSell2.50L₹1.2Cr48.522.67L → 17.1K0.02%-0.29 pp7(2)told 25 Dec 2024
26 Dec 2024Harshit H Mehta HUFPromoterSell4.00L₹2.0Cr49.016.67L → 2.67L0.32%-0.48 pp7(2)told 25 Dec 2024
5 Dec 2024Rishit Haresh MehtaPromoterSell4.00L₹1.8Cr45.021.09Cr → 1.05Cr12.65%-0.48 pp7(2)told 4 Dec 2024
5 Dec 2024Rishit Haresh MehtaPromoterSell14.00L₹6.3Cr45.011.23Cr → 1.09Cr13.13%-1.69 pp7(2)told 4 Dec 2024
20 Nov 2024Shweta Harshit MehtaPromoterSell9.00L₹4.6Cr50.6572.60L → 63.60L7.66%-1.08 pp7(2)told 20 Nov 2024
20 Nov 2024Rita Haresh MehtaPromoterSell18.00L₹9.1Cr50.6986.28L → 68.28L8.20%-2.16 pp7(2)told 20 Nov 2024
20 Nov 2024Harshit H Mehta HUFPromoterSell52.9K₹26.8L50.657.20L → 6.67L0.80%-0.06 pp7(2)told 20 Nov 2024

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 25 Sept 2026

CSV
12 of 78 deals
By year
DateDealClientQuantityPriceValue
25 Sept 2026Sell · bulkSAVITRIBEN MAHENDRAKUMAR SHAH4.38L27.22₹1.2Cr
4 Aug 2026Buy · bulkL7 HITECH PRIVATE LIMITED4.30L48.32₹2.1Cr
27 Mar 2026Buy · bulkR G FAMILY TRUST42.57L33.93₹14.4Cr
27 Mar 2026Sell · bulkRG HUF42.57L33.93₹14.4Cr
25 Mar 2026Buy · bulkR G FAMILY TRUST14.00L37.67₹5.3Cr
25 Mar 2026Sell · bulkRAVI GOYAL (HUF)14.00L37.67₹5.3Cr
23 Jan 2026Buy · bulkALTIZEN VENTURES LLP8.65L54.00₹4.7Cr
23 Jan 2026Sell · bulkALTIZEN VENTURES LLP7.07L52.69₹3.7Cr
23 Jan 2026Buy · bulkVISHAL MAHESH WAGHELA5.10L53.41₹2.7Cr
24 Sept 2025Sell · bulkARYAMAN CAPITAL MARKETS LIMITED6.50L48.02₹3.1Cr
27 Jun 2025Sell · bulkPASHUPATI CAPITA SER PVT LTD12.06L41.50₹5.0Cr
27 Jun 2025Buy · bulkPASHUPATI CAPITA SER PVT LTD1.52L48.99₹74.5L

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 26 Oct 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.

Price band: 10% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations29.841.330.839.339.541.338.352.658.756.869.474.0
Other income0.30.60.30.71.40.30.71.70.72.91.21.3
Total income30.041.931.140.040.941.638.954.459.459.770.675.3
Total expenses28.037.728.937.937.435.936.550.955.551.467.272.0
└ Finance costs0.20.20.20.20.30.50.30.20.40.90.40.4
└ Depreciation0.70.70.80.70.80.80.80.70.80.80.70.8
Profit before tax2.14.22.22.13.55.72.43.53.88.33.33.3
Tax expense0.61.10.60.60.91.40.60.91.02.50.80.9
Net profit1.43.11.61.62.64.31.82.62.95.92.52.4
EPS0.170.370.190.190.320.520.220.310.350.710.300.29
Net margin4.85%7.50%5.13%3.95%6.63%10.51%4.75%4.88%4.89%10.31%3.63%3.22%
PBT margin6.93%10.27%7.06%5.42%8.86%13.80%6.36%6.60%6.53%14.64%4.81%4.42%
Tax rate29.94%26.99%27.41%27.12%25.11%23.82%25.30%26.08%25.05%29.60%24.60%27.26%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 9 Nov 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets87.4102.396.299.0119.6137.4153.4202.0
Current assets64.580.673.877.096.7113.8128.9176.8
└ Cash & equivalents0.91.00.20.11.10.31.93.6
└ Other bank balances1.31.30.00.00.00.00.00.0
└ Current investments0.00.01.41.41.51.51.81.9
└ Trade receivables36.156.049.651.457.257.482.0120.2
└ Inventories19.715.816.317.126.741.430.034.2
Total equity43.847.652.455.562.366.975.580.3
└ Attributable to owners43.847.652.455.562.366.975.580.3
└ Share capital16.616.616.616.616.616.616.616.6
Borrowings9.86.68.111.414.711.918.832.3
└ Current8.26.47.210.814.311.918.527.7
└ Non-current1.50.20.90.60.40.00.34.6
Trade payables31.042.931.529.034.753.649.382.6
Current liabilities41.553.142.842.757.070.477.6117.1
Total liabilities43.654.743.843.557.370.577.9121.7
Net debt7.64.36.59.912.210.115.126.8
Debt / equity0.220.140.150.210.240.180.250.40
Current ratio1.551.521.721.801.701.621.661.51

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow8.20.72.42.14.90.65.94.3
└ Capex0.00.00.0(0.0)0.00.00.0(2.3)
Free cash flow8.20.72.42.14.90.65.92.0
Investing cash flow(6.6)(0.4)(2.7)(1.2)(3.5)(1.2)(4.5)(2.4)
Financing cash flow(1.8)(0.2)(0.5)(0.3)(0.5)(0.3)(0.6)(0.3)
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(0.3)0.1(0.7)0.70.9(0.8)0.81.7

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

MEDICO at a glance

  • MEDICO closed at ₹18.54 on 20 Nov 2026, -1.44% on the day, -65.1% over one year, 67.4% below its 52-week high of ₹56.88.
  • Delivery was 61.3% of traded quantity on 20 Nov 2026, the 55th percentile of its own 1,113 sessions with a reading (20-session average 70.6%, 1-year average 58.9%).
  • Market capitalisation is ₹154 crore at a trailing P/E of 11.3 (trailing EPS ₹1.64).
  • Q2 FY27 results (standalone, filed 9 Nov 2026): revenue ₹74 crore (+40.5% year on year), net profit ₹2 crore (-7.4%); the price moved +0.2% on the first session after.
  • Promoters held 61.38% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 5 Feb 2027 and 12 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE630Y01024
SeriesEQ
Listed26 May 2022
NSE market cap · 17 Nov 2026₹154 Cr
Free-float market cap (NSE)₹60 Cr
Shares outstanding (NSE)8.30Cr
History from26 May 2022
Sessions1,115

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.